同期放化疗作为原发性中枢神经系统神经母细胞瘤的辅助治疗。
Concurrent Chemoradiotherapy as an Adjuvant Treatment of Primary Central Nervous System Neuroblastoma.
机构信息
University of Tunis El Manar, Faculty of Medicine of Tunis, Ariana, Tunisia.
Department of Radiation Oncology, Abderrahmen Mami Hospital, Ariana, Tunisia.
出版信息
Perm J. 2022 Jun 29;26(2):166-171. doi: 10.7812/TPP/21.147. Epub 2022 Jun 17.
Abstract
Primary central nervous system neuroblastoma is a rare malignant embryonal tumor. With only few cases reported in the literature, data on regardingthe diagnosis and management of these tumors are limited. We reported a case of primary cerebral neuroblastoma in a 20-year-old woman complaining of progressive headaches. The patient underwent subtotal tumor resection and adjuvant concurrent chemoradiotherapy. The prescription dose was 54 Gy. She remained free of recurrence for 14 months after the end of radiotherapy treatment.
摘要
原发性中枢神经系统神经母细胞瘤是一种罕见的恶性胚胎瘤。由于文献中仅报道了少数病例，因此关于这些肿瘤的诊断和治疗的数据有限。我们报告了一例 20 岁女性原发性脑神经母细胞瘤病例，该患者主诉进行性头痛。患者接受了肿瘤次全切除术和辅助同步放化疗。处方剂量为 54Gy。放疗结束后 14 个月，患者无复发。
相似文献
1
Concurrent Chemoradiotherapy as an Adjuvant Treatment of Primary Central Nervous System Neuroblastoma.
Perm J. 2022 Jun 29;26(2):166-171. doi: 10.7812/TPP/21.147. Epub 2022 Jun 17.
2
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
J Clin Oncol. 1996 Sep;14(9):2417-26. doi: 10.1200/JCO.1996.14.9.2417.
3
A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
BMC Cancer. 2020 Feb 18;20(1):130. doi: 10.1186/s12885-020-6592-2.
4
[A case of malignant peritoneal mesothelioma successfully treated with concurrent chemoradiotherapy].
Gan To Kagaku Ryoho. 2011 Dec;38(13):2639-41.
5
[Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
Zhonghua Er Ke Za Zhi. 2014 Jul;52(7):540-3.
6
Surgical treatment versus concurrent chemoradiotherapy as an initial treatment modality in advanced olfactory neuroblastoma.
Auris Nasus Larynx. 2007 Dec;34(4):493-8. doi: 10.1016/j.anl.2007.02.005. Epub 2007 May 11.
7
Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants.
J Pediatr Hematol Oncol. 2003 Dec;25(12):934-40. doi: 10.1097/00043426-200312000-00005.
8
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.
Lancet Oncol. 2012 Feb;13(2):163-71. doi: 10.1016/S1470-2045(11)70320-5. Epub 2011 Dec 7.
9
Primary cerebral neuroblastoma: a case treated with adjuvant chemotherapy and radiotherapy.
Turk J Pediatr. 2004 Apr-Jun;46(2):182-5.
10
[A Patient with Primary Intraventricular Gliosarcoma and Long-term Survival - a Case Report].
Klin Onkol. 2016 Winter;29(6):454-459. doi: 10.14735/amko2016454.
本文引用的文献
1
Incidence, Treatment, and Survival in Primary Central Nervous System Neuroblastoma.
World Neurosurg. 2020 Aug;140:e61-e72. doi: 10.1016/j.wneu.2020.04.145. Epub 2020 Apr 25.
2
Central nervous system (CNS) neuroblastoma. A case-based update.
Childs Nerv Syst. 2018 May;34(5):817-823. doi: 10.1007/s00381-018-3764-3. Epub 2018 Mar 8.
3
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9.
4
Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma.
Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):858-62. doi: 10.1016/j.ijrobp.2014.07.019. Epub 2014 Sep 20.
5
Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project.
J Clin Oncol. 2014 Oct 1;32(28):3169-76. doi: 10.1200/JCO.2014.56.1621. Epub 2014 Aug 25.
6
Neurocognitive function after radiotherapy for paediatric brain tumours.
Nat Rev Neurol. 2012 Oct;8(10):578-88. doi: 10.1038/nrneurol.2012.182. Epub 2012 Sep 11.
7
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial.
J Clin Oncol. 2012 Sep 10;30(26):3187-93. doi: 10.1200/JCO.2011.39.8719. Epub 2012 Jul 30.
8
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.
J Clin Oncol. 2009 Jan 10;27(2):289-97. doi: 10.1200/JCO.2008.16.6785. Epub 2008 Dec 1.
9
Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy.
Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):499-508. doi: 10.1016/j.ijrobp.2005.12.002. Epub 2006 Mar 6.
10
Primary cerebral neuroblastoma: a case treated with adjuvant chemotherapy and radiotherapy.
Turk J Pediatr. 2004 Apr-Jun;46(2):182-5.
Zotero 插件